Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring

More women are living with and surviving breast cancer, because of improvements in breast cancer care. Trastuzumab (Herceptin®▾) has significantly improved outcomes for women with HER2-positive tumours. Concerns about the cardiac effects of trastuzumab (which fundamentally differ from the permanent...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, A L, Barlow, M, Barrett-Lee, P J, Canney, P A, Gilmour, I M, Robb, S D, Plummer, C J, Wardley, A M, Verrill, M W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653760/
https://www.ncbi.nlm.nih.gov/pubmed/19259090
http://dx.doi.org/10.1038/sj.bjc.6604909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653760/
https://www.ncbi.nlm.nih.gov/pubmed/19259090
http://dx.doi.org/10.1038/sj.bjc.6604909

Ejemplares similares